BindingDB logo
myBDB logout

BDBM50120309 CHEMBL108189::Peptide Boronic Acid analogue

SMILES: CC(C)[C@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)CC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@@H]1C(=O)N[C@@H](Cc1ccccc1)B1O[C@@H]2C[C@@H]3C[C@@H](C3(C)C)[C@]2(C)O1

InChI Key: InChIKey=LLEUUNMVDOWADP-RRPYQFALSA-N

Data: 1 KI  1 IC50

Find this compound or compounds like it in BindingDB or PDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 50120309   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kcal/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
Hepatitis C virus serine protease, NS3/NS4A


(Hepatitis C virus)
BDBM50120309
PNG
(CHEMBL108189 | Peptide Boronic Acid analogue)
Show SMILES CC(C)[C@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)CC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@@H]1C(=O)N[C@@H](Cc1ccccc1)B1O[C@@H]2C[C@@H]3C[C@@H](C3(C)C)[C@]2(C)O1
Show InChI InChI=1S/C42H63BN6O11/c1-22(2)34(47-37(55)27(15-16-32(50)51)45-36(54)26(44)21-33(52)53)39(57)48-35(23(3)4)40(58)49-17-11-14-28(49)38(56)46-31(18-24-12-9-8-10-13-24)43-59-30-20-25-19-29(41(25,5)6)42(30,7)60-43/h8-10,12-13,22-23,25-31,34-35H,11,14-21,44H2,1-7H3,(H,45,54)(H,46,56)(H,47,55)(H,48,57)(H,50,51)(H,52,53)/t25-,26-,27-,28+,29-,30+,31-,34-,35-,42-/m0/s1
PDB
MMDB

UniProtKB/TrEMBL

B.MOAD
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Similars

PubMed
500n/an/an/an/an/an/an/an/a



Bristol-Myers Squibb Pharmaceutical Research Institute

Curated by ChEMBL


Assay Description
Binding affinity against Hepatitis C virus NS3 protease


Bioorg Med Chem Lett 12: 3199-202 (2002)


BindingDB Entry DOI: 10.7270/Q2R49Q38
More data for this
Ligand-Target Pair
Chymotrypsin


(Homo sapiens (Human))
BDBM50120309
PNG
(CHEMBL108189 | Peptide Boronic Acid analogue)
Show SMILES CC(C)[C@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)CC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@@H]1C(=O)N[C@@H](Cc1ccccc1)B1O[C@@H]2C[C@@H]3C[C@@H](C3(C)C)[C@]2(C)O1
Show InChI InChI=1S/C42H63BN6O11/c1-22(2)34(47-37(55)27(15-16-32(50)51)45-36(54)26(44)21-33(52)53)39(57)48-35(23(3)4)40(58)49-17-11-14-28(49)38(56)46-31(18-24-12-9-8-10-13-24)43-59-30-20-25-19-29(41(25,5)6)42(30,7)60-43/h8-10,12-13,22-23,25-31,34-35H,11,14-21,44H2,1-7H3,(H,45,54)(H,46,56)(H,47,55)(H,48,57)(H,50,51)(H,52,53)/t25-,26-,27-,28+,29-,30+,31-,34-,35-,42-/m0/s1
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Similars

PubMed
n/an/a 70n/an/an/an/an/an/a



Bristol-Myers Squibb Pharmaceutical Research Institute

Curated by ChEMBL


Assay Description
Inhibitory concentration against Human pancreatic Serine protease chymotrypsin


Bioorg Med Chem Lett 12: 3199-202 (2002)


BindingDB Entry DOI: 10.7270/Q2R49Q38
More data for this
Ligand-Target Pair